Article Versions Notes

Toribio-García I, Olivares-Hernández A, Miramontes-González JP, Posado-Domínguez L, Martín García A, Eiros Bachiller R, Figuero-Pérez L, Garijo Martínez M, Roldán Ruiz J, Bellido Hernández L, et al. Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data. Cancers. 2023; 15(17):4293. https://doi.org/10.3390/cancers15174293

Toribio-García, Irene, Alejandro Olivares-Hernández, José Pablo Miramontes-González, Luis Posado-Domínguez, Ana Martín García, Rocío Eiros Bachiller, Luis Figuero-Pérez, María Garijo Martínez, Jonnathan Roldán Ruiz, Lorena Bellido Hernández, and et al. 2023. "Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data" Cancers 15, no. 17: 4293. https://doi.org/10.3390/cancers15174293

Toribio-García, I., Olivares-Hernández, A., Miramontes-González, J. P., Posado-Domínguez, L., Martín García, A., Eiros Bachiller, R., Figuero-Pérez, L., Garijo Martínez, M., Roldán Ruiz, J., Bellido Hernández, L., Fonseca-Sánchez, E., Luis Sánchez, P., & del Barco-Morillo, E. (2023). Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data. Cancers, 15(17), 4293. https://doi.org/10.3390/cancers15174293